@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP473825.RAyroJl2Bd7q49RnmjsLwCyPiAEnP7F5ODhs5kmT_wHgs130_head { this: np:hasAssertion dgn-np:NP473825.RAyroJl2Bd7q49RnmjsLwCyPiAEnP7F5ODhs5kmT_wHgs130_assertion; np:hasProvenance dgn-np:NP473825.RAyroJl2Bd7q49RnmjsLwCyPiAEnP7F5ODhs5kmT_wHgs130_provenance; np:hasPublicationInfo dgn-np:NP473825.RAyroJl2Bd7q49RnmjsLwCyPiAEnP7F5ODhs5kmT_wHgs130_publicationInfo; a np:Nanopublication . dgn-np:NP473825.RAyroJl2Bd7q49RnmjsLwCyPiAEnP7F5ODhs5kmT_wHgs130_assertion a np:Assertion . dgn-np:NP473825.RAyroJl2Bd7q49RnmjsLwCyPiAEnP7F5ODhs5kmT_wHgs130_provenance a np:Provenance . dgn-np:NP473825.RAyroJl2Bd7q49RnmjsLwCyPiAEnP7F5ODhs5kmT_wHgs130_publicationInfo a np:PublicationInfo . } dgn-np:NP473825.RAyroJl2Bd7q49RnmjsLwCyPiAEnP7F5ODhs5kmT_wHgs130_assertion { miriam-gene:3383 a ncit:C16612 . lld:C0242379 a ncit:C7057 . dgn-gda:DGN347124cb93664272c050fb843b108a38 sio:SIO_000628 miriam-gene:3383, lld:C0242379; a sio:SIO_001121 . } dgn-np:NP473825.RAyroJl2Bd7q49RnmjsLwCyPiAEnP7F5ODhs5kmT_wHgs130_provenance { dgn-np:NP473825.RAyroJl2Bd7q49RnmjsLwCyPiAEnP7F5ODhs5kmT_wHgs130_assertion dcterms:description "[This concept is based on the following findings: (a) engagement of beta1 integrins on certain lung cancer cells by a specific antibody or by ligand matrices such as fibronectin and collagen markedly reduced ICAM-1 expression on the cell surface and induced sICAM-1; (b) down-regulation of ICAM-1 by stimulation of beta1 integrins was abrogated by tyrosine kinase inhibitors or by transfection of dominant negative truncations of focal adhesion kinase (FAK); (c) engagement of beta1 integrins also reduced ICAM-1-dependent adhesion of lung cancer cells to T cells, a process completely inhibited by tyrosine kinase inhibitors and by transfection of dominant negative forms of FAK; and (d) stimulation of beta1 integrins prevented killing of lung cancer cells by autologous CTLs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:11280762; prov:wasDerivedFrom dgn-void:befree-20150227; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20150227 pav:importedOn "2015-02-27"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP473825.RAyroJl2Bd7q49RnmjsLwCyPiAEnP7F5ODhs5kmT_wHgs130_publicationInfo { this: dcterms:created "2015-08-25T14:42:19+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v3.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v3.0.0" . }